We are live on ! Find out more
AVNS icon

Avanos Medical

291 hedge funds and large institutions have $1.92B invested in Avanos Medical in 2021 Q1 according to their latest regulatory filings, with 46 funds opening new positions, 60 increasing their positions, 80 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed

39% more first-time investments, than exits

New positions opened: 46 | Existing positions closed: 33

4% more funds holding

Funds holding: 281291 (+10)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

2.56% less ownership

Funds ownership: 94.41%91.85% (-2.6%)

7% less capital invested

Capital invested by funds: $2.07B → $1.92B (-$142M)

25% less repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 80

Holders
291
Holders Change
+10
Holders Change %
+3.56%
% of All Funds
5.11%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
46
Increased
60
Reduced
80
Closed
33
Calls
$1.3M
Puts
Net Calls
+$1.3M
Net Calls Change
+$193K

AVNS Hedge Fund Activity: Q1 2021 in Review

291 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Avanos Medical (AVNS) for Q1 2021, worth a combined $1.92B — down 6.9% from $2.07B a quarter earlier.

Buyers outnumbered sellers: 46 funds opened new AVNS positions and 33 closed out — a net gain of 13 holders — while 60 added to existing stakes and 80 trimmed.

The largest buyer was BlackRock, adding an estimated $13.5M. The largest seller was Champlain Investment Partners, cutting an estimated $26.2M.

  • 291 institutional investors held Avanos Medical (AVNS) as of Q1 2021, up from 281 in Q4 2020.
  • Funds reported $1.92B of Avanos Medical stock for Q1 2021, down 6.9% quarter-over-quarter.
  • 46 funds opened new Avanos Medical positions in Q1 2021 and 33 closed out, a net change of +13 holders.
  • The largest Avanos Medical buyer in Q1 2021 was BlackRock, an estimated $13.5M added.
  • The largest Avanos Medical seller in Q1 2021 was Champlain Investment Partners, an estimated $26.2M sold.

Based on aggregated 13F filings for Q1 2021.